Brief: Elicera Therapeutics Enters Collaboration With Spanish Research Institution
18/10/2022 14:03
Oct 18 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* ELICERA THERAPEUTICS ENTERS FIRST INTERNATIONAL
COLLABORATION
INVOLVING THE ITANK PLATFORM WITH A SPANISH RESEARCH INSTITUTION
* AGREEMENT DOES NOT GRANT JCLRI ANY INTELLECTUAL PROPERTY
RIGHTS
TO ITANK-PLATFORM, AND ANY PATENTABLE INVENTIONS ARISING FROM
PROJECT SHALL BECOME JOINT PROPERTY OF ELICERA AND JCLRI
Source text for Eikon: ID:nWkr1Zh69q
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent